Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear

Brain Research

Volumn 1559, Issue , 2014, Pages 1-10

  Gould, Thomas J ^a   Wilkinson, Derek S ^a   Yildirim, Emre ^a   Blendy, Julie A ^b   Adoff, Michael D ^a  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acetylcholine; Addiction; Cognition; Learning; Receptor binding; Withdrawal

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; NICOTINIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; FEAR; FOLLOW UP; HIPPOCAMPUS; LEARNING; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TOBACCO DEPENDENCE; TREATMENT DURATION; WITHDRAWAL SYNDROME; ANIMAL; C57BL MOUSE; CATALEPSY; DOSE RESPONSE; DRUG EFFECTS; DRUG TOLERANCE; METABOLISM; PHYSIOLOGY; TIME; UPREGULATION;

MUS;

ANIMALS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEAR; FREEZING REACTION, CATALEPTIC; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO USE DISORDER; UP-REGULATION;

EID: 84897530964     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.02.038     Document Type: Article

References (73)

1. J.M. André, D. Gulick, G.S. Portugal, and T.J. Gould Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice Behav. Brain Res. 190 2008 174 181
2. R.L. Ashare, M. Falcone, and C. Lerman Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment Neuropharmacology 2013
3. Association American Psychiatric, 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text rev. Washington, DC.
4. T.B. Baker, and S.T. Tiffany Morphine tolerance as habituation Psychol. Rev. 92 1985 78 108
5. D.J. Balfour The pharmacology of nicotine dependence: a working hypothesis Pharmacol. Ther. 15 1981 239 250 (Pubitemid 12128592)
6. A.E. Bullock, A.L. Clark, S.R. Grady, S.F. Robinson, B.S. Slobe, M.J. Marks, and A.C. Collins Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes J. Neurochem. 68 1997 2412 2423 (Pubitemid 27218162)
7. A.C. Collins, Y. Luo, S. Selvaag, and M.J. Marks Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion J. Pharmacol. Exp. Ther. 271 1994 125 133 (Pubitemid 24333121)
8. A.C. Collins, and M.J. Marks Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev. Res. 38 1996 231 242 (Pubitemid 27034040)
9. A.C. Collins, E. Romm, and J.M. Wehner Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors Brain Res. Bull. 25 1990 373 379 (Pubitemid 20346567)
10. J.A. Dani, and S. Heinemann Molecular and cellular aspects of nicotine abuse Neuron 16 1996 905 908 (Pubitemid 26171196)
11. J.A. Davis, and T.J. Gould Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits Eur. Neuropsychopharmacol. 19 2009 551 561
12. J.A. Davis, J.R. James, S.J. Siegel, and T.J. Gould Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice J. Neurosci. 25 2005 8708 8713 (Pubitemid 41362049)
13. T.J. Gould, and J.S. Higgins Nicotine enhances contextual fear conditioning in C57BL/6 J mice at 1 and 7 days post-training Neurobiol. Learn. Mem. 80 2003 147 157 (Pubitemid 36970236)
14. T.J. Gould, and P.T. Leach Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning Neurobiol. Learn. Mem. 107 2013 108 132
15. T.J. Gould, G.S. Portugal, J.M. André, M.P. Tadman, M.J. Marks, J.W. Kenney, E. Yildirim, and M. Adoff The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation Neuropharmacology 62 2012 2118 2125
16. T.J. Gould, and J.M. Wehner Nicotine enhancement of contextual fear conditioning Behav. Brain Res. 102 1999 31 39 (Pubitemid 29314566)
17. S.J. Heishman Behavioral and cognitive effects of smoking: relationship to nicotine addiction Nicot. Tob. Res. 1 S2 1999 (S143-147; discussion S165-146)
18. S.J. Heishman, B.A. Kleykamp, and E.G. Singleton Meta-analysis of the acute effects of nicotine and smoking on human performance Psychopharmacology (Berl) 210 2010 453 469
19. P.S. Hendricks, J.W. Ditre, D.J. Drobes, and T.H. Brandon The early time course of smoking withdrawal effects Psychopharmacology (Berl) 187 2006 385 396 (Pubitemid 44079930)
20. K.S. Hudmon, R.L. Corelli, and A.V. Prokhorov Current approaches to pharmacotherapy for smoking cessation Ther. Adv. Respir. Dis. 4 2010 35 47
21. J.R. Hughes, R.M. Keenan, and A. Yellin Effect of tobacco withdrawal on sustained attention Addict. Behav. 14 1989 577 580 (Pubitemid 19258435)
22. B.A. Hulihan-Giblin, M.D. Lumpkin, and K.J. Kellar Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine J. Pharmacol. Exp. Ther. 252 1990 21 25 (Pubitemid 20067688)
23. G.P. Hussmann, J.R. Turner, E. Lomazzo, R. Venkatesh, V. Cousins, Y. Xiao, R.P. Yasuda, B.B. Wolfe, D.C. Perry, A.H. Rezvani, E.D. Levin, J.A. Blendy, and K.J. Kellar Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain J. Pharmacol. Exp. Ther. 343 2012 441 450
24. L.K. Jacobsen, J.H. Krystal, W.E. Mencl, M. Westerveld, S.J. Frost, and K.R. Pugh Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers Biol. Psychiatry 57 2005 56 66 (Pubitemid 39647592)
25. L.K. Jacobsen, W.E. Mencl, R.T. Constable, M. Westerveld, and K.R. Pugh Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers Psychopharmacology (Berl) 193 2007 557 566 (Pubitemid 47094373)
26. M.E. Jarvik, and J.E. Henningfield Pharmacological treatment of tobacco dependence Pharmacol. Biochem. Behav. 30 1988 279 294 (Pubitemid 19268821)
27. J.W. Kenney, C. Florian, G.S. Portugal, T. Abel, and T.J. Gould Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine Neuropsychopharmacology 35 2010 483 492
28. J.W. Kenney, and T.J. Gould Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine Mol. Neurobiol. 38 2008 101 121
29. J.W. Kenney, J.D. Raybuck, and T.J. Gould Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning Hippocampus 22 2012 1681 1690
30. J.J. Kim, R.A. Rison, and M.S. Fanselow Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear Behav. Neurosci. 107 1993 1093 1098 (Pubitemid 24018220)
31. K.M. Kleinman, R.L. Vaughn, and T.S. Christ Effects of cigarette smoking and smoking deprivation on paired-associate learning of high and low meaningful nonsense syllables Psychol. Rep. 32 1973 963 966
32. E.D. Levin, C. Lee, J.E. Rose, A. Reyes, G. Ellison, M. Jarvik, and E. Gritz Chronic nicotine and withdrawal effects on radial-arm maze performance in rats Behav. Neural Biol. 53 1990 269 276 (Pubitemid 20249740)
33. E.D. Levin, A.H. Rezvani, Y. Xiao, S. Slade, M. Cauley, C. Wells, D. Hampton, A. Petro, J.E. Rose, M.L. Brown, M.A. Paige, B.E. McDowell, and K.J. Kellar Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats J. Pharmacol. Exp. Ther. 332 2010 933 939
34. S.F. Logue, R. Paylor, and J.M. Wehner Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task Behav. Neurosci. 111 1997 104 113 (Pubitemid 27097521)
35. J. Loughead, R. Ray, E.P. Wileyto, K. Ruparel, P. Sanborn, S. Siegel, R.C. Gur, and C. Lerman Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers Biol. Psychiatry 67 2010 715 721
36. M.J. Marks, J.B. Burch, and A.C. Collins Effects of chronic nicotine infusion on tolerance development and nicotinic receptors J. Pharmacol. Exp. Ther. 226 1983 817 825 (Pubitemid 13007732)
37. M.J. Marks, E. Romm, D.K. Gaffney, and A.C. Collins Nicotine-induced tolerance and receptor changes in four mouse strains J. Pharmacol. Exp. Ther. 237 1986 809 819 (Pubitemid 16088097)
38. M.J. Marks, J.A. Stitzel, and A.C. Collins Time course study of the effects of chronic nicotine infusion on drug response and brain receptors J. Pharmacol. Exp. Ther. 235 1985 619 628 (Pubitemid 16210725)
39. S.E. McCallum, A.R. Caggiula, S. Booth, C.R. Breese, M.J. Lee, E.C. Donny, S. Leonard, and A.F. Sved Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats Psychopharmacology (Berl) 150 2000 1 8 (Pubitemid 30350807)
40. A. Mendrek, J. Monterosso, S.L. Simon, M. Jarvik, A. Brody, R. Olmstead, C.P. Domier, M.S. Cohen, M. Ernst, and E.D. London Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence Addict. Behav. 31 2006 833 844
41. K.B. Mihalak, F.I. Carroll, and C.W. Luetje Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol. Pharmacol. 70 2006 801 805 (Pubitemid 44268437)
42. C.S. Myers, R.C. Taylor, E.T. Moolchan, and S.J. Heishman Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray Neuropsychopharmacology 33 2008 588 598
43. E.L. Ochoa, A. Chattopadhyay, and M.G. McNamee Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators Cell. Mol. Neurobiol. 9 1989 141 178 (Pubitemid 19178149)
44. M. Paolini, and M. De Biasi Mechanistic insights into nicotine withdrawal Biochem. Pharmacol. 2011 1 12
45. R.L. Papke, C. Trocmé-Thibierge, D. Guendisch, S.A.A. Al Rubaiy, and S.A. Bloom Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists J. Pharmacol. Exp. Ther. 337 2011 367 379
46. F. Patterson, C. Jepson, J. Loughead, K. Perkins, A.A. Strasser, S. Siegel, J. Frey, R. Gur, and C. Lerman Working memory deficits predict short-term smoking resumption following brief abstinence Drug Alcohol Depend. 106 2010 61 64
47. F. Patterson, C. Jepson, A.A. Strasser, J. Loughead, K.A. Perkins, R.C. Gur, J.M. Frey, S. Siegel, and C. Lerman Varenicline improves mood and cognition during smoking abstinence Biol. Psychiatry 65 2009 144 149
48. R.E. Penton, M.W. Quick, and R.A.J. Lester Short- and long-lasting consequences of in vivo nicotine treatment on hippocampal excitability J. Neurosci. 31 2011 2584 2594
49. K.A. Perkins Chronic tolerance to nicotine in humans and its relationship to tobacco dependence Nicot. Tob. Res. 4 2002 405 422 (Pubitemid 35469975)
50. K.A. Perkins, D. Gerlach, M. Broge, J.E. Grobe, M. Sanders, C. Fonte, J. Vender, C. Cherry, and A. Wilson Dissociation of nicotine tolerance from tobacco dependence in humans J. Pharmacol. Exp. Ther. 296 2001 849 856 (Pubitemid 32187357)
51. G.S. Portugal, and T.J. Gould Nicotine withdrawal disrupts new contextual learning Pharmacol. Biochem. Behav. 92 2009 117 123
52. G.S. Portugal, J.W. Kenney, and T.J. Gould Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning Neurobiol. Learn. Mem. 89 2008 106 113 (Pubitemid 350235960)
53. G.S. Portugal, D.S. Wilkinson, J.W. Kenney, C. Sullivan, and T.J. Gould Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning Behav. Genet. 42 2012 133 150
54. G.S. Portugal, D.S. Wilkinson, J.R. Turner, J.A. Blendy, and T.J. Gould Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning Neurobiol. Learn. Mem. 97 2012 482 494
55. C.X. Poulos, and H. Cappell Homeostatic theory of drug tolerance: a general model of physiological adaptation Psychol. Rev. 98 1991 390 408
56. J.D. Raybuck, and T.J. Gould Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice - a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors Eur. J. Neurosci. 29 2009 377 387
57. J.D. Raybuck, G.S. Portugal, C. Lerman, and T.J. Gould Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice Behav. Neurosci. 122 2008 1166 1171
58. J.D. Rhodes, L.W. Hawk, R.L. Ashare, N.J. Schlienz, and M.C. Mahoney The effects of varenicline on attention and inhibitory control among treatment-seeking smokers Psychopharmacology (Berl) 223 2012 131 138
59. S.E. Robinson, J.R. James, L.N. Lapp, R.E. Vann, D.F. Gross, S.D. Philibin, and J.A. Rosecrans Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance Psychopharmacology (Berl) 184 2006 306 313 (Pubitemid 43255847)
60. S.E. Robinson, R.E. Vann, A.F. Britton, M.M. OConnell, J.R. James, and J.A. Rosecrans Cellular nicotinic receptor desensitization correlates with nicotine-induced acute behavioral tolerance in rats Psychopharmacology (Berl) 192 2007 71 78 (Pubitemid 46673889)
61. R. Salas, A. Main, D. Gangitano, and M. De Biasi Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit Neuropharmacology 53 2007 863 869 (Pubitemid 350018825)
62. R.D. Schwartz, and K.J. Kellar Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo Science 220 1983 214 216 (Pubitemid 13115272)
63. B.M. Sharp, and H.S. Beyer Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin J. Pharmacol. Exp. Ther. 238 1986 486 491 (Pubitemid 16039585)
64. F.R. Snyder, F.C. Davis, and J.E. Henningfield The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery Drug Alcohol Depend. 23 1989 259 266 (Pubitemid 19148670)
65. R.L. Solomon, and J.D. Corbit An opponent-process theory of motivation. II. Cigarette addiction J. Abnorm. Psychol. 81 1973 158 171
66. A. Tatum, M. Seevers, and K. Collins Morphine addiction and its physiological interpretation based on experimental evidences J. Pharmacol. Exp. Ther. 36 1929 401 410
67. J.R. Turner, L.M. Castellano, and J.A. Blendy Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior J. Pharmacol. Exp. Ther. 334 2010 665 672
68. J.R. Turner, L.M. Castellano, and J.A. Blendy Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline Nicotine Tob. Res. 13 2011 41 46
69. J.R. Turner, D.S. Wilkinson, R.L. Poole, T.J. Gould, G.C. Carlson, and J.A. Blendy Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal Neuropsychopharmacology 38 2013 2035 2047
70. D.S. Wilkinson, and T.J. Gould Withdrawal from chronic nicotine and subsequent sensitivity to nicotine challenge on contextual learning Behav. Brain Res. 250 2013 58 61
71. D.S. Wilkinson, J.R. Turner, J.A. Blendy, and T.J. Gould Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus Psychopharmacology (Berl) 225 2013 201 208
72. Y. Xiao, H. Fan, J.L. Musachio, Z.-l. Wei, S.K. Chellappan, A.P. Kozikowski, and K.J. Kellar Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them Mol. Pharmacol. 70 2006 1454 1460 (Pubitemid 44435998)
73. R. Zwart, A.L. Carbone, M. Moroni, I. Bermudez, A.J. Mogg, E.A. Folly, L.M. Broad, A.C. Williams, D. Zhang, C. Ding, B.A. Heinz, and E. Sher Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors Mol. Pharmacol. 73 2008 1838 1843 (Pubitemid 351724371)